Canadian Agency for Drugs and Technologies in Health. (2018). Pharmacoeconomic review report: Guselkumab (Tremfya) (Janssen Inc.). CADTH.
Cita Chicago Style (17a ed.)Canadian Agency for Drugs and Technologies in Health. Pharmacoeconomic Review Report: Guselkumab (Tremfya) (Janssen Inc.). Ottawa (ON): CADTH, 2018.
Cita MLA (9a ed.)Canadian Agency for Drugs and Technologies in Health. Pharmacoeconomic Review Report: Guselkumab (Tremfya) (Janssen Inc.). CADTH, 2018.
Precaución: Estas citas no son 100% exactas.